Simplify Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.2M Buy
504,918
+177,561
+54% +$7.63M 0.34% 16
2026
Q1
$12M Buy
+327,357
New +$15.5M 0.18% 18
2024
Q3
Sell
-39,427
Closed -$5.63M 123
2024
Q2
$5.63M Buy
+39,427
New +$5.22M 0.38% 28

Other funds holding NVO

Simplify Asset Management's NVO Position: Q2 2026 in Review

Simplify Asset Management increased its Novo Nordisk (NVO) stake by 54% in Q2 2026, buying an estimated $7.63M and bringing the position to 504,918 shares worth $24.2M. The position accounts for 0.34% of the portfolio, ranked #16.

Simplify Asset Management first reported a position in NVO in Q2 2024 and has held it in 3 quarters since. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Simplify Asset Management held 504,918 shares of Novo Nordisk worth $24.2M as of Q2 2026.
  • Simplify Asset Management bought 177,561 Novo Nordisk shares in Q2 2026, an estimated $7.63M.
  • Novo Nordisk made up 0.34% of Simplify Asset Management's portfolio in Q2 2026, its #16 holding.
  • Simplify Asset Management first reported a position in Novo Nordisk in Q2 2024 and has held it in 3 quarters since.
  • 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.